| Literature DB >> 30342708 |
Yongzhi Zeng1, Kun Ren1, Xiao Zhu1, Zhi Zheng1, Guanghui Yi1.
Abstract
Long noncoding RNAs (lncRNAs) are an important group of pervasive noncoding RNAs (>200nt) proposed to be crucial regulators of numerous physiological and pathological processes. Through interactions with RNA, chromatin, and protein, lncRNAs modulate mRNA stability, chromatin structure, and the function of proteins (including transcription factors). In addition, to their well-known roles in the modulation of cell growth, apoptosis, neurological disease progression and cancer metastasis, these large molecules have also been identified as likely mediators of lipid metabolism. In particular, lncRNAs orchestrate adipogenesis; fatty acid, cholesterol, and phospholipid metabolism and transport; and the formation of high-density and low-density lipoproteins (HDLs and LDLs). LncRNAs also appear to target several transcription factors that play essential roles in the regulation of lipid metabolism, such as liver X receptors (LXRs), sterol regulatory element binding proteins (SREBPs), and peroxisome proliferator-activated receptor γ (PPARγ). Better understanding the regulatory roles of lncRNAs in dyslipidemia, atherosclerosis, and adipogenesis will reveal appropriate strategies to treat these diseases. In this review, we review recent progress in lncRNA-mediated regulation of lipid metabolism, as well as its role in the regulation of adipogenesis.Entities:
Keywords: Adipogenesis; Dyslipidemias; Lipids metabolism; Long non-coding RNAs; Metabolic disease
Mesh:
Substances:
Year: 2018 PMID: 30342708 DOI: 10.1016/bs.acc.2018.07.001
Source DB: PubMed Journal: Adv Clin Chem ISSN: 0065-2423 Impact factor: 5.394